The Trends of Viral Hepatitis B and C and HIV Infections in Donated Bloods in Iran Between 2003 and 2017

References

• Mohammadali F, Pourfathollah AA. Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005–2011. Arch Iran Med. 2014;17(9):613–620.25204477
   PubMed Web of Science ®Google Scholar
• Flichman DM, Blejer JL, Livellara BI, et al. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors. BMC Infect Dis. 2014;14(1):218. doi:10.1186/1471-2334-14-21824755089
   PubMed Web of Science ®Google Scholar
• Mohsenizadeh M, Mollaei HR, Ghaziizadeh M. Seroepidemiological study of hepatitis B, C and HIV among blood donors in Kerman. APJCP. 2017;18(12):3267. doi:10.22034/APJCP.2017.18.1.2329286218
   PubMedGoogle Scholar
• Kasraian L. National disasters in Iran and blood donation: Bam earthquake experience. Iran Red Crescent Med J. 2010;12(3):316.
   Web of Science ®Google Scholar
• Bahadorimonfared A, Soori H, Mehrabi Y, et al. Trends of fatal road traffic injuries in Iran (2004–2011). PLoS One. 2013;8(5):e65198. doi:10.1371/journal.pone.006519823724132
   PubMed Web of Science ®Google Scholar
• Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Ahmadi AB, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon. 2009;9(3).
   Web of Science ®Google Scholar
• Salehi-Vaziri M, Sadeghi F, Hashiani AA, Fesharaki MG, Alavian SM. Hepatitis B virus infection in the general population of Iran: an updated systematic review and meta-analysis. Hepat Mon. 2016;16(4). doi:10.5812/hepatmon
   Web of Science ®Google Scholar
• Saber HR, Tabatabaee SM, Abasian A, et al. Incidence and residual risk of HIV, HBV and HCV infections among blood donors in Tehran. Indian J Hematol Blood Transfus. 2017;33(3):412–416. doi:10.1007/s12288-016-0732-528824247
   PubMed Web of Science ®Google Scholar
• Tessema B, Yismaw G, Kassu A, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010;10(1):111. doi:10.1186/1471-2334-10-11120459703
   PubMed Web of Science ®Google Scholar
• Sajjadi SM, Pourfathollah AA, Mohammadi S, Nouri B, Hassanzadeh R, Rad F. The prevalence and trends of hepatitis B, hepatitis C, and HIV among voluntary blood donors in kohgiluyeh and boyer-ahmad transfusion center, Southwestern Iran. Iran J Public Health. 2018;47(7):944.30181991
   PubMed Web of Science ®Google Scholar
• Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348–355. doi:10.1093/ije/dyw09827283160
   PubMed Web of Science ®Google Scholar
• Gómez LA, Penuela O, Higuera F. Prevalence of antibodies against transfusion-transmissible infections (TTI) in blood donors from the Colombian eastern region. Clin Lab. 2014;60(5):869–871. doi:10.7754/clin.lab.2013.13070324839834
   PubMed Web of Science ®Google Scholar
• Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol. 2006;21(4):299–305. doi:10.1007/s10654-006-0001-216685581
   PubMed Web of Science ®Google Scholar
• Yadav B, Varma A, Singh P, Kumar R, Bandi P. Seroprevalence of Transfusion-Transmitted Infections (TTIs) in blood donors: a study from Central India. Int J Med Sci Public Health. 2016;5(6):1–5. doi:10.5455/ijmsph.
   Google Scholar
• Romanò L, Velati C, Cambiè G, et al. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection. Blood Transfus. 2013;11(2):281.23399361
   PubMed Web of Science ®Google Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–1555. doi:10.1016/S0140-6736(15)61412-X26231459
   PubMed Web of Science ®Google Scholar
• Amini Kafi‐abad S, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion (Paris). 2009;49(10):2214–2220. doi:10.1111/j.1537-2995.2009.02245.x
   PubMed Web of Science ®Google Scholar
• Mahdaviani F, Saremi S, Maghsoudlu M, Pourfathollah AA. Prevalence of blood transmitted viral infections in regular and non-regular donors of Arak Blood Center. Sci JIBTO. 2006;2(7):343–351.
   Google Scholar
• Kasraiyan L, Torab Gahromi SA. Frequency of blood donation for HIV check up at Shiraz Blood Transfusion Organization. JMUMS. 2006;16(51):95–101.
   Google Scholar
• Musavi H, Rahimi H, Kooti W, et al. Prevalence of human immunodeficiency virus in Iranian blood donors: a systematic review and meta-analysis. Arch Iran Med. 2018;21(6):260.29940745
   PubMed Web of Science ®Google Scholar
• Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol. 2015;21(38):10790. doi:10.3748/wjg.v21.i38.1079026478671
   PubMed Web of Science ®Google Scholar
• Cheraghali A. Overview of blood transfusion system of Iran: 2002–2011. Iran J Public Health. 2012;41(8):89.
   Web of Science ®Google Scholar
• Maghsudlu M, Nasizadeh S, Abolghasemi H, Ahmadyar S. Blood donation and donor recruitment in Iran from 1998 through 2007: ten years’ experience. Transfusion (Paris). 2009;49(11):2346–2351. doi:10.1111/trf.2009.49.issue-11
   Web of Science ®Google Scholar
• Mousavi F, Tavabi A, Golestan B, et al. Knowledge, attitude and practice towards blood donation in Iranian population. Transfus Med. 2011;21(5):308–317. doi:10.1111/j.1365-3148.2011.01080.x21696474
   PubMed Web of Science ®Google Scholar